Medical Devices Investors & VC Firms
1641 firms in this list, with a median first check of $500K. 343 of them lead rounds. Generated from verified public data and updated continuously.
Saints Capital
San FranciscoGrowth–Late Stage
18 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
116 people
Blackbird Ventures
SydneyPre-Seed–Series B$149K – $60M
51 people
Lerer Hippeau
New YorkSeed–Series B$500K – $2M
22 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
Connecticut Innovations
New HavenPre-Seed–Growth$500K – $2M
35 people
Atlas Venture
CambridgeSeed–Series B$500K – $1M
84 people
JAFCO Group
TokyoPre-Seed–Growth
89 people
Sofinnova Partners
ParisSeed–Late Stage$540K – $27M
79 people
Deerfield Management Company
New YorkGrowth–Late Stage
97 people
Abstract Ventures
San FranciscoPre-Seed–Series C$250K – $750K
6 people
Korea Investment Partners
SeoulSeed–Series C$3M – $10M
80 people
Hellman & Friedman
San FranciscoGrowth–Late Stage
102 people
Atinum Investment Co. Ltd.
SeoulSeries B–Growth$100K – $2M
44 people
Frazier Healthcare Partners
SeattleGrowth$50M – $400M
91 people
Correlation Ventures
San FranciscoPre-Seed–Series A$100K – $4M
19 people
ARCH Venture Partners
ChicagoSeed–Series C$50K – $250M
46 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
Foresite Capital
West HollywoodSeed–Late Stage
44 people
Triton Partners
LondonSeed–Growth
105 people
50 Partners
ParisPre-Seed–Seed
81 people
i5invest
San FranciscoSeed
70 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
61 people
Cerity Partners Ventures
New YorkSeed–Late Stage
61 people
Related lists
Investors & VC Firms in North America (12829)Investors & VC Firms in United States (11877)Investors & VC Firms in Europe (5831)Investors & VC Firms in Global (4737)AI & Machine Learning Investors & VC Firms (4564)Fintech Investors & VC Firms (4547)SaaS Investors & VC Firms (4223)Healthtech Investors & VC Firms (4191)Enterprise Software Investors & VC Firms (4100)Crypto & Web3 Investors & VC Firms (3974)
Data sourced from public filings and firms' own websites — see our methodology.







































































































